Abstract:Rheumatoid arthritis (RA) is characterized by formation of synovial ectopic lymphoid structures (ELS) supporting B cell autoreactivity toward locally generated citrullinated (cit) antigens, including those contained in neutrophil extracellular traps (NETs). However, only a minority of RA-rmAbs from B cells isolated from ELS+ RA tissues react against NETs. Thus, alternative cellular sources of other potential autoantigens targeted by locally differentiated B cells remain undefined. RA fibroblast-like synoviocytes (FLS) have been implicated in the release of RA-associated autoantigens. In this study, we aimed to define stromal-derived autoantigens from RA-FLS targeted by RA-rmAbs. Seventy-one RA-rmAbs were screened toward RA-FLS by living-cell immunofluorescence (IF). Western blotting was used to identify potential autoantigens from RA-FLS protein extracts. Putative candidates were validated using colocalization immunofluorescence confocal microscopy, ELISA, immunoprecipitation assay, and surface plasmon resonance on unmodified/cit proteins. Serum immunoreactivity was tested in anti-citrullinated peptide/protein Abs (ACPA)+ versus ACPA- RA patients. Ten out of 71 RA-rmAbs showed clear reactivity toward RA-FLS in immunofluorescence with no binding to NETs. One stromal-reactive RA-rmAb (RA057/11.89.1) decorated a ∼58-kDa band that mass spectrometry and Western blotting with a commercial Ab identified as calreticulin (CRT). Confocal microscopy demonstrated significant cellular colocalization between anti-CRT RA057/11.89.1 in RA-FLS. RA057/11.89.1 was able to immunoprecipitate rCRT. Deimination of CRT to cit-CRT moderately increased RA057/11.89.1 immunoreactivity. cit-CRT displayed increased blocking capacity compared with unmodified CRT in competitive binding assays. Finally, anti-cit-CRT Abs were preferentially detected in ACPA+ versus ACPA- RA sera. We identified a synovial B cell-derived RA-rmAb locally differentiated within the ELS+ RA synovium reacting toward CRT, a putative novel autoantigen recently described in RA patients, suggesting that FLS-derived CRT may contribute to fuel the local autoimmune response.

CD1dhiCD5+ B Cells Differentiate into Antibody-Secreting Cells under the Stimulation with Calreticulin Fragment

Antibody-Secreting Cells under the Stimulation with Calreticulin Fragment ESEARCH ARTICLE R

Recombinant Murine Calreticulin Fragment 39-272 Expands Cd1d(Hi)Cd5(+) Il-10-Secreting B Cells That Modulate Experimental Autoimmune Encephalomyelitis in C57bl/6 Mice

Modulation of cellular immunity by antibodies against calreticulin.

Functional Analysis of Recombinant Calreticulin Fragment 39-272: Implications for Immunobiological Activities of Calreticulin in Health and Disease

Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin.

Immunological Activities of Calreticulin

Calreticulin Fragment 39-272 Promotes B16 Melanoma Malignancy Through Myeloid-Derived Suppressor Cells in Vivo.

Self-Oligomerization Is Essential For Enhanced Immunological Activities Of Soluble Recombinant Calreticulin

Immunological Activity Difference Between Native Calreticulin Monomers and Oligomers

Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma

Soluble Calreticulin Induces Tumor Necrosis Factor-Α (Tnf-Α) and Interleukin (IL)-6 Production by Macrophages Through Mitogen-Activated Protein Kinase (MAPK) and NFκB Signaling Pathways.

Membrane Bound CRT Fragment Accelerates Tumor Growth of Melanoma B16 Cell In Vivo through Promoting M2 Polarization via TLR4

FULL-LENGTH cDNA CLONING AND EXPRESSION ANALYSIS OF CALRETICULIN GENE FROM HYRIOPSIS CUMINGII

Roles of calreticulin on anti-tumor effection

Characterization of a Synovial B Cell–Derived Recombinant Monoclonal Antibody Targeting Stromal Calreticulin in the Rheumatoid Joints

Calreticulin regulates hepatic stellate cell activation through modulating TGF-beta-induced Smad signaling.

Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway

Calreticulin As a Hydrophilic Chimeric Molecular Adjuvant Enhances IgG Responses to the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus.

Adjuvanticity of a Recombinant Calreticulin Fragment in Assisting Anti-Β-glucan IgG Responses in T Cell-Deficient Mice.

Identification and characterization of calreticulin as a novel plasminogen receptor